Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
55 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2016 Summary
Global Markets Direct's, 'Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2016', provides an overview of the Sunovion Pharmaceuticals Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Sunovion Pharmaceuticals Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Sunovion Pharmaceuticals Inc. - The report provides overview of Sunovion Pharmaceuticals Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Sunovion Pharmaceuticals Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Sunovion Pharmaceuticals Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to buy
- Evaluate Sunovion Pharmaceuticals Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Sunovion Pharmaceuticals Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Sunovion Pharmaceuticals Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 5 Sunovion Pharmaceuticals Inc. Snapshot 6 Sunovion Pharmaceuticals Inc. Overview 6 Key Information 6 Key Facts 6 Sunovion Pharmaceuticals Inc. - Research and Development Overview 7 Key Therapeutic Areas 7 Sunovion Pharmaceuticals Inc. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Partnered Products 12 Partnered Products/Combination Treatment Modalities 13 Sunovion Pharmaceuticals Inc. - Pipeline Products Glance 14 Sunovion Pharmaceuticals Inc. - Late Stage Pipeline Products 14 Pre-Registration Products/Combination Treatment Modalities 14 Phase III Products/Combination Treatment Modalities 15 Sunovion Pharmaceuticals Inc. - Clinical Stage Pipeline Products 16 Phase II Products/Combination Treatment Modalities 16 Phase I Products/Combination Treatment Modalities 17 Sunovion Pharmaceuticals Inc. - Early Stage Pipeline Products 18 IND/CTA Filed Products/Combination Treatment Modalities 18 Preclinical Products/Combination Treatment Modalities 19 Discovery Products/Combination Treatment Modalities 20 Sunovion Pharmaceuticals Inc. - Drug Profiles 21 eslicarbazepine acetate 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 dasotraline 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 glycopyrrolate 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 DSP-2230 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 DSP-3748 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 SEP-363856 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 SEP-360 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 SEP-39 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Small Molecule 1 for Neuropsychiatric Disorders 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Small Molecule for Neuropsychiatric Disorders 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 Small Molecule to Inhibit D-amino acid oxidase for Neuropathic Pain, Inflammatory Pain and Memory Impairment 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 EP-103 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 Small Molecules for Central Nervous System Disorders 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 Small Molecules to Modulate GPCR and Ion Channel for Psychiatric Disorders 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 Sunovion Pharmaceuticals Inc. - Pipeline Analysis 39 Sunovion Pharmaceuticals Inc. - Pipeline Products by Target 39 Sunovion Pharmaceuticals Inc. - Pipeline Products by Route of Administration 41 Sunovion Pharmaceuticals Inc. - Pipeline Products by Molecule Type 42 Sunovion Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action 43 Sunovion Pharmaceuticals Inc. - Recent Pipeline Updates 45 Sunovion Pharmaceuticals Inc. - Dormant Projects 51 Sunovion Pharmaceuticals Inc. - Discontinued Pipeline Products 52 Discontinued Pipeline Product Profiles 52 dasotraline 52 DSP-1053 52 DSP-8658 52 SEP-228432 52 tecastemizole 52 Sunovion Pharmaceuticals Inc. - Locations and Subsidiaries 53 Head Office 53 Other Locations & Subsidiaries 53 Appendix 54 Methodology 54 Coverage 54 Secondary Research 54 Primary Research 54 Expert Panel Validation 54 Contact Us 54 Disclaimer 55
List of Tables
Sunovion Pharmaceuticals Inc., Key Information 6 Sunovion Pharmaceuticals Inc., Key Facts 6 Sunovion Pharmaceuticals Inc. - Pipeline by Indication, 2016 8 Sunovion Pharmaceuticals Inc. - Pipeline by Stage of Development, 2016 10 Sunovion Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2016 11 Sunovion Pharmaceuticals Inc. - Partnered Products in Pipeline, 2016 12 Sunovion Pharmaceuticals Inc. - Partnered Products/ Combination Treatment Modalities, 2016 13 Sunovion Pharmaceuticals Inc. - Pre-Registration, 2016 14 Sunovion Pharmaceuticals Inc. - Phase III, 2016 15 Sunovion Pharmaceuticals Inc. - Phase II, 2016 16 Sunovion Pharmaceuticals Inc. - Phase I, 2016 17 Sunovion Pharmaceuticals Inc. - IND/CTA Filed, 2016 18 Sunovion Pharmaceuticals Inc. - Preclinical, 2016 19 Sunovion Pharmaceuticals Inc. - Discovery, 2016 20 Sunovion Pharmaceuticals Inc. - Pipeline by Target, 2016 39 Sunovion Pharmaceuticals Inc. - Pipeline by Route of Administration, 2016 41 Sunovion Pharmaceuticals Inc. - Pipeline by Molecule Type, 2016 42 Sunovion Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2016 43 Sunovion Pharmaceuticals Inc. - Recent Pipeline Updates, 2016 45 Sunovion Pharmaceuticals Inc. - Dormant Developmental Projects,2016 51 Sunovion Pharmaceuticals Inc. - Discontinued Pipeline Products, 2016 52 Sunovion Pharmaceuticals Inc., Other Locations 53 Sunovion Pharmaceuticals Inc., Subsidiaries 53
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.